Skip to main content

Practice Management

Practice Management

Can Generics Help Heal Our Ailing Healthcare System?

Dalia Buffery, MA, ABD

Practice Management

Predictive and Prognostic Models: Implications for Healthcare Decision-Making in a Modern Recession

F. Randy Vogenberg, PhD, FASHP

Stakeholder Perspective

Potential Benefits of Prediction Models from Large Electronic Databases

by Jason Roy, PhD

Practice Management

Impact of Prescription Benefit Coverage Limits on Sevelamer Hydrochloride Adherence for Patients with ESRD

Bharati Bhardwaja, PharmD, BCPS, Nikki Carroll, MS, Eli Korner, PharmD, Kavita V. Nair, PhD

Stakeholder Perspective

Balancing Horizontal and Vertical Equity within Managed Health Plans Drug Benefit

by Jack E. Fincham, PhD, RPh

Practice Management

Private Health Plans Perspectives: Electronic Personal Health Records and Electronic Prescribing

Nancy M. McGee, JD, MPH, Gene Reeder, RPh, PhD, Timothy S. Regan, BPharm, RPh, CPh, J.D. Kleinke, Steve Arnold, MD, MS, MBA, CPE

Stakeholder Perspective

Electronic PHRs and e-Prescribing: Not Quite There Yet

by Gary M. Owens, MD

Practice Management

Bundled Payment: A Promising Initiative of Payment Reform

Practice Management

Impact of 2 Copay Waivers in a Generic Incentive Program

Anthony F. Liu, MSCS, Tom Jecklin, Geoffery Lee, James Hogan

Practice Management

Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels

F. Randy Vogenberg, PhD, FASHP

Stakeholder Perspective

The Many Challenges of Pay-for-Performance Programs

by Gary M. Owens, MD

Practice Management

Impact of Etanercept Treatment on Absenteeism and Productivity: The Work Loss and Productivity Survey

Denise Globe, PhD, Peter Mazonson, MD, MBA, Chris Santas, MBA, Regina Murphy, MBA, Annie Cheng, Xingyue Huang, PhD, Arthur Kavanaugh, MD

Stakeholder Perspective

What Is the Value of Specialty Pharmaceuticals?

Page 32 of 32
Results 311 - 318 of 318